LongevityResearch Phase

Humanin

Subcutaneous injection, Intravenous

Overview

A 24-amino acid mitochondrial-derived peptide encoded within the 16S rRNA region of mitochondrial DNA. Humanin exerts cytoprotective and neuroprotective effects by interacting with IGFBP-3, BAX, and the FPRL-1 receptor.

Mechanism of Action

It inhibits apoptosis through suppression of the intrinsic mitochondrial death pathway and reduces amyloid-beta-induced neurotoxicity..

Research Summary & Key Findings

Discovered in 2001 as a survival factor against Alzheimer's disease-related neuronal death. Studies show protection against oxidative stress, atherosclerosis, and age-related cognitive decline. Circulating humanin levels inversely correlate with age and Alzheimer's disease progression (Hashimoto et al., PNAS, 2001).

Clinical Status

Research Phase

Humanin is in the research phase with limited clinical data in humans. Current evidence is primarily derived from preclinical (animal or in vitro) studies.

Administration Routes

Subcutaneous injectionIntravenous

Related Peptides in Longevity

Find a Provider

Find a verified provider who offers Humanin therapy in your area.

Browse Provider Map

Find a Pharmacy

Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply Humanin.

Pharmacy Directory

Join the Association

Access exclusive peptide protocols, provider resources, and community support.

List Your Practice

Disclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol.